Abstract
We evaluated the efficacy and safety of topiramate for migraine prophylaxis among Chinese patients in a multicenter prospective observational study. We found that topiramate at low doses was effective in preventing migraine headache in Chinese patients and was generally well tolerated. There was no difference in baseline headache frequency or intensity between responders and nonresponders.
Publication types
-
Clinical Trial
-
Multicenter Study
MeSH terms
-
Adult
-
Asian People
-
Female
-
Fructose / analogs & derivatives*
-
Fructose / therapeutic use
-
Humans
-
Male
-
Middle Aged
-
Migraine Disorders / epidemiology*
-
Migraine Disorders / prevention & control*
-
Neuroprotective Agents / therapeutic use*
-
Observation
-
Prospective Studies
-
Time Factors
-
Topiramate
Substances
-
Neuroprotective Agents
-
Topiramate
-
Fructose